相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Több támadáspontú gyógyszerek: múlt, jelen és jövő
Péter Mátyus
ORVOSI HETILAP (2020)
Interaction of Mycotoxin Alternariol with Serum Albumin
Eszter Fliszar-Nyul et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation
Marko Salmi et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Interactions of 7,8-Dihydroxyflavone with Serum Albumin as well as with CYP2C9, CYP2C19, CYP3A4, and Xanthine Oxidase Biotransformation Enzymes
Eszter Fliszar-Nyul et al.
BIOMOLECULES (2019)
Fluorescence spectroscopic evaluation of the interactions of quercetin, isorhamnetin, and quercetin-3 '-sulfate with different albumins
Miklos Poor et al.
JOURNAL OF LUMINESCENCE (2018)
Analgesic effects of the novel semicarbazide-sensitive amine oxidase inhibitor SZV 1287 in mouse pain models with neuropathic mechanisms: Involvement of transient receptor potential vanilloid 1 and ankyrin 1 receptors
Adam Horvath et al.
PHARMACOLOGICAL RESEARCH (2018)
Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics
Zelma Faisal et al.
MYCOTOXIN RESEARCH (2018)
Interaction of 2R-ochratoxin A with Serum Albumins: Binding Site, Effects of Site Markers, Thermodynamics, Species Differences of Albumin-binding, and Influence of Albumin on Its Toxicity in MDCK Cells
Zelma Faisal et al.
TOXINS (2018)
Interaction of Chrysin and Its Main Conjugated Metabolites Chrysin-7-Sulfate and Chrysin-7-Glucuronide with Serum Albumin
Violetta Mohos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Interaction of mycotoxin zearalenone with human serum albumin
Miklos Poor et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2017)
Analgesic and Anti-Inflammatory Effects of the Novel Semicarbazide-Sensitive Amine-Oxidase Inhibitor SzV-1287 in Chronic Arthritis Models of the Mouse
Adam Horvath et al.
SCIENTIFIC REPORTS (2017)
Metabolism-Activated Multitargeting (MAMUT): An Innovative Multitargeting Approach to Drug Design and Development
Peter Matyus et al.
CHEMMEDCHEM (2016)
A NOVEL 3-(4,5-DIPHENYL-1,3-OXAZOL-2-YL)PROPANAL OXIME COMPOUND IS A POTENT TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1 AND VANILLOID 1 (TRPA1 AND V1) RECEPTOR ANTAGONIST
M. Payrits et al.
NEUROSCIENCE (2016)
Interaction of Citrinin with Human Serum Albumin
Miklos Poor et al.
TOXINS (2015)
Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters
James J. P. Stewart
JOURNAL OF MOLECULAR MODELING (2013)
Subdomain IB Is the Third Major Drug Binding Region of Human Serum Albumin: Toward the Three-Sites Model
Ferenc Zsila
MOLECULAR PHARMACEUTICS (2013)
Human serum albumin: From bench to bedside
Gabriella Fanali et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Evaluation of drug-human serum albumin binding interactions with support vector machine aided online automated docking
Ferenc Zsila et al.
BIOINFORMATICS (2011)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Drug binding to human serum albumin: Abridged review of results obtained with high-performance liquid chromatography and circular dichroism
Giorgio A. Ascoli et al.
CHIRALITY (2006)
Structural basis of the drug-binding specificity of human serum albumin
J Ghuman et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
分享论文
